The Valley Desk

Clinical trial reportJournal of Crohn's & colitisPublished

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of Crohn's & colitis
Published
Subject terms
Humans; Crohn Disease; Body Weight; Gastrointestinal Agents; Treatment Outcome; Remission Induction; Injections, Subcutaneous; Severity of Illness Index; Adolescent; Child; Female; Male
PubMed ID
41843763
PubMed Central ID
PMC13017028
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal